| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/06/2023 | 20.68% | Barclays | $47 → $59 | Upgrades | Equal-Weight → Overweight |
| 10/19/2023 | 14.54% | Goldman Sachs | $51 → $56 | Upgrades | Neutral → Buy |
| 09/18/2023 | 28.86% | Stifel | → $63 | Reiterates | Buy → Buy |
| 08/04/2023 | -3.87% | Barclays | $41 → $47 | Maintains | Equal-Weight |
| 05/05/2023 | -7.96% | Barclays | $51 → $45 | Maintains | Equal-Weight |
| 03/29/2023 | 32.95% | UBS | $66 → $65 | Maintains | Buy |
| 03/07/2023 | 4.32% | Barclays | $37 → $51 | Maintains | Equal-Weight |
| 03/02/2023 | -3.87% | Goldman Sachs | $41 → $47 | Maintains | Neutral |
| 03/01/2023 | 20.68% | Wells Fargo | $48 → $59 | Maintains | Overweight |
| 03/01/2023 | -3.87% | Goldman Sachs | $41 → $47 | Maintains | Neutral |
| 03/01/2023 | 28.86% | Stifel | $44 → $63 | Upgrades | Hold → Buy |
| 02/15/2023 | 22.72% | Guggenheim | $63 → $60 | Maintains | Buy |
| 01/31/2023 | 8.41% | Williams Trading | → $53 | Upgrades | Hold → Buy |
| 12/12/2022 | -16.14% | Goldman Sachs | $36 → $41 | Maintains | Neutral |
| 11/07/2022 | -24.32% | Barclays | $40 → $37 | Maintains | Equal-Weight |
| 10/19/2022 | -10% | Wells Fargo | $48 → $44 | Maintains | Overweight |
| 07/25/2022 | -12.05% | Williams Capital | → $43 | Downgrades | Buy → Hold |
| 07/21/2022 | -30.46% | Goldman Sachs | $41 → $34 | Maintains | Neutral |
| 07/11/2022 | -18.18% | Wells Fargo | → $40 | Initiates Coverage On | → Overweight |
| 06/10/2022 | -16.14% | Goldman Sachs | $55 → $41 | Downgrades | Buy → Neutral |
| 06/09/2022 | -7.96% | Barclays | $53 → $45 | Downgrades | Overweight → Equal-Weight |
| 06/08/2022 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
| 05/18/2022 | -7.96% | Stifel | $50 → $45 | Maintains | Hold |
| 11/05/2021 | 77.95% | Barclays | $86 → $87 | Maintains | Overweight |
| 07/14/2021 | 41.13% | Goldman Sachs | → $69 | Initiates Coverage On | → Buy |
| 05/25/2021 | 98.4% | UBS | $89 → $97 | Maintains | Buy |
| 04/07/2021 | — | UBS | Upgrades | Neutral → Buy | |
| 12/10/2020 | -14.09% | Goldman Sachs | $38 → $42 | Downgrades | Buy → Neutral |
| 10/07/2020 | -34.55% | Barclays | → $32 | Upgrades | Equal-Weight → Overweight |
| 07/27/2020 | -50.91% | Goldman Sachs | $17 → $24 | Upgrades | Sell → Buy |
| 07/22/2020 | -59.09% | UBS | → $20 | Initiates Coverage On | → Neutral |
| 06/05/2020 | — | Susquehanna | Upgrades | Neutral → Positive | |
| 06/03/2020 | — | Piper Sandler | Upgrades | Neutral → Overweight | |
| 05/08/2020 | -57.05% | Stifel | $24 → $21 | Maintains | Hold |
| 05/05/2020 | -38.64% | Guggenheim | $40 → $30 | Maintains | Buy |
| 04/29/2020 | — | Susquehanna | Downgrades | Positive → Neutral | |
| 04/15/2020 | -50.91% | Stifel | $28 → $24 | Maintains | Hold |
| 04/14/2020 | -59.09% | Barclays | $32 → $20 | Maintains | Equal-Weight |
| 04/06/2020 | -59.09% | Susquehanna | $43 → $20 | Maintains | Positive |
| 03/25/2020 | -65.23% | Goldman Sachs | → $17 | Downgrades | Neutral → Sell |
| 03/06/2020 | -28.41% | Stifel | $43 → $35 | Maintains | Hold |
| 02/18/2020 | -12.05% | Stifel | → $43 | Downgrades | Buy → Hold |
| 01/24/2020 | -5.91% | Odeon Capital | → $46 | Initiates Coverage On | → Buy |
| 11/13/2019 | -28.41% | Barclays | → $35 | Initiates Coverage On | → Equal-Weight |
| 10/22/2019 | — | Macquarie | Initiates Coverage On | → Neutral | |
| 08/09/2019 | -42.73% | B of A Securities | $24 → $28 | Reiterates | → Underperform |
| 06/17/2019 | -28.41% | Guggenheim | → $35 | Initiates Coverage On | → Buy |
| 06/17/2019 | -40.68% | Piper Sandler | → $29 | Initiates Coverage On | → Neutral |
| 06/13/2019 | -26.37% | Susquehanna | → $36 | Initiates Coverage On | → Positive |
| 06/06/2019 | -50.91% | B of A Securities | → $24 | Initiates Coverage On | → Underperform |
| 05/28/2019 | -5.91% | Stifel | → $46 | Initiates Coverage On | → Buy |
What is the target price for Kontoor Brands (KTB)?
The latest price target for Kontoor Brands (NYSE: KTB) was reported by Barclays on November 6, 2023. The analyst firm set a price target for $59.00 expecting KTB to rise to within 12 months (a possible 20.68% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kontoor Brands (KTB)?
The latest analyst rating for Kontoor Brands (NYSE: KTB) was provided by Barclays, and Kontoor Brands upgraded their overweight rating.
When is the next analyst rating going to be posted or updated for Kontoor Brands (KTB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kontoor Brands, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kontoor Brands was filed on November 6, 2023 so you should expect the next rating to be made available sometime around November 6, 2024.
Is the Analyst Rating Kontoor Brands (KTB) correct?
While ratings are subjective and will change, the latest Kontoor Brands (KTB) rating was a upgraded with a price target of $47.00 to $59.00. The current price Kontoor Brands (KTB) is trading at is $48.89, which is within the analyst's predicted range.